UNH UnitedHealth Group Incorporated Common Stock (DE)
$390,56
Fiyat · May 20, 2026
Temel veriler itibarıyla May 5, 2026
52 Haftlık Aralık
$235–$404
92% of range
Analist Derecelendirmesi
BUY
34 analysts
Fiyat Hedefi
$387
P/E (TTM)
25.0
ROE
12.0%
Net Kâr Marjı
2.7%
UNH Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$390.56
Piyasa Değeri
$299.08B
P/E (TTM)
25.0
EPS (TTM)
$13.23
Gelir (TTM)
$447.57B
Temettü Verimi
2.6%
ROE
12.0%
D/E Borç/Özsermaye
0.7
52 Haftlık Aralık
$235 – $404
UNH Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
Configure
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Gelir ve Net Gelir
$447.57B
2020-12-31
→
2025-12-31
Hisse Başına Kâr
$13.23
2020-12-31
→
2025-12-31
Serbest Nakit Akışı
$16.07B
2020-12-31
→
2025-12-31
Marjlar
2.7%
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
Metrik
5 Yıllık trend
UNH
Akran Ortalaması
P/E (TTM)
25.0
23.9
P/S (TTM) (F/S (TTM))
0.7
0.7
P/B (F/D)
3.0
3.6
EV / EBITDA
18.1
—
Price / FCF (Fiyat / Serbest Nakit Akışı)
18.6
—
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
Metrik
5 Yıllık trend
UNH
Akran Ortalaması
Operating Margin (Faaliyet Kâr Marjı)
4.2%
—
Net Profit Margin (Net Kâr Marjı)
2.7%
0.98%
ROA
4.0%
2.7%
ROE
12.0%
7.8%
ROIC
9.6%
—
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
Metrik
5 Yıllık trend
UNH
Akran Ortalaması
Debt / Equity (Borç / Öz Sermaye)
0.7
46.0
Current Ratio (Cari Oran)
0.8
1.6
Quick Ratio (Cari Oran)
0.4
—
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
Metrik
5 Yıllık trend
UNH
Akran Ortalaması
Revenue YoY (Gelir Yıllık Bazda)
11.8%
—
Revenue CAGR 3Y (Gelir 3 Yıllık Bileşik Büyüme Oranı)
11.3%
—
Revenue CAGR 5Y (Gelir 5 Yıllık Bileşik Büyüme Oranı)
11.7%
—
EPS YoY (EPS YB)
-14.7%
—
Net Income YoY (Net Gelir Yıllık Bazda)
-16.3%
—
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
Metrik
5 Yıllık trend
UNH
Akran Ortalaması
Payout Ratio (Temettü Ödeme Oranı)
65.7%
—
Temettüler Temettü verimi, ödeme oranı, temettü geçmişi, 5 Yıllık CAGR
Temettü Verimi
2.6%
Temettü Ödeme Oranı
65.7%
5 Yıllık Temettü CAGR
—
| Ex-tarihi | Miktar |
|---|---|
| 09 Mart 2026 | $2,2100 |
| 08 Aralık 2025 | $2,2100 |
| 15 Eylül 2025 | $2,2100 |
| 16 Haziran 2025 | $2,2100 |
| 10 Mart 2025 | $2,1000 |
| 09 Aralık 2024 | $2,1000 |
| 16 Eylül 2024 | $2,1000 |
| 17 Haziran 2024 | $2,1000 |
| 08 Mart 2024 | $1,8800 |
| 01 Aralık 2023 | $1,8800 |
| 08 Eylül 2023 | $1,8800 |
| 15 Haziran 2023 | $1,8800 |
| 10 Mart 2023 | $1,6500 |
| 02 Aralık 2022 | $1,6500 |
| 09 Eylül 2022 | $1,6500 |
| 16 Haziran 2022 | $1,6500 |
| 11 Mart 2022 | $1,4500 |
| 03 Aralık 2021 | $1,4500 |
| 10 Eylül 2021 | $1,4500 |
| 18 Haziran 2021 | $1,4500 |
UNH Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
AL
34 analist
- Güçlü Al 7 20,6%
- Al 19 55,9%
- Tut 7 20,6%
- Sat 0 0,0%
- Güçlü Sat 1 2,9%
12 Aylık Fiyat Hedefi
26 analist · 2026-05-16
Medyan
$400.00
Ortalama
$387.27
Şimdi
$390.56
Düşük
$287.00
Yüksek
$444.00
Medyan hedef
$400.00
+2,4%
Ortalama hedef
$387.27
-0,8%
Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
Ort. Sürpriz
0.01%
| Dönem | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|
| 31 Mart 2026 | $7.23 | $6.64 | 0.59% |
| 31 Aralık 2025 | $2.11 | $2.12 | -0.01% |
| 30 Eylül 2025 | $2.92 | $2.82 | 0.10% |
| 30 Haziran 2025 | $4.08 | $4.53 | -0.45% |
| 31 Mart 2025 | $7.20 | $7.36 | -0.16% |
Eş Karşılaştırması Anahtar metrikler sektördeki benzerlerine karşı
| Hisse Sembolü | Piyasa Değeri | P/E | Gelir YoY | Net Kar Marjı | ROE | Brüt Kar Marjı |
|---|---|---|---|---|---|---|
| UNH | $299.08B | 25.0 | 11.8% | 2.7% | 12.0% | — |
| ELV | $77.37B | 13.9 | 12.5% | 2.8% | 13.3% | — |
| HUM | $50.90B | 26.0 | 10.1% | 0.92% | 7.0% | — |
| CNC | $20.24B | -3.0 | 19.4% | -3.4% | -28.8% | 7.3% |
| MOH | $8.85B | 19.5 | 11.8% | 1.0% | 10.9% | — |
| HQY | $7.12B | 34.0 | 9.5% | 16.4% | 10.1% | 69.5% |
| ALHC | $4.03B | — | 46.1% | -0.02% | -0.52% | — |
| PGNY | $2.14B | 39.5 | 10.4% | 4.5% | 11.3% | 23.6% |
| CLOV | — | -5.1 | 40.3% | -4.5% | -26.2% | — |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu 14
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $447.57B | $400.28B | $371.62B | $324.16B | $287.60B | $257.14B | $242.16B | $226.25B | $201.16B | $184.84B | $157.11B | $130.47B | |
| Cost of Revenue | $50.66B | $46.69B | $38.77B | $33.70B | $31.03B | $30.75B | $28.12B | $27.00B | $24.11B | $24.42B | $16.21B | $3.83B | |
| SG&A Expense | $59.59B | $53.01B | $54.63B | $47.78B | $42.58B | $41.70B | $35.19B | $34.07B | $29.56B | $28.40B | $24.31B | $21.26B | |
| Operating Expenses | $428.60B | $367.99B | $339.26B | $295.73B | $263.63B | $234.74B | $222.47B | $208.90B | $185.95B | $171.91B | $146.09B | $120.20B | |
| Operating Income | $18.96B | $32.29B | $32.36B | $28.43B | $23.97B | $22.41B | $19.68B | $17.34B | $15.21B | $12.93B | $11.02B | $10.27B | |
| Interest Expense | $4.00B | $3.91B | $3.25B | $2.09B | $1.66B | $1.66B | $1.70B | $1.40B | $1.19B | $1.07B | $790M | $618M | |
| Pretax Income | $14.70B | $20.07B | $29.11B | $26.34B | $22.31B | $20.74B | $17.98B | $15.94B | $14.02B | $11.86B | $10.23B | $9.66B | |
| Income Tax | $1.89B | $4.83B | $5.97B | $5.70B | $4.58B | $4.97B | $3.74B | $3.56B | $3.20B | $4.79B | $4.36B | $4.04B | |
| Net Income | $12.06B | $14.40B | $22.38B | $20.12B | $17.29B | $15.40B | $13.84B | $11.99B | $10.56B | $7.02B | $5.81B | $5.62B | |
| EPS (Basic) | $13.28 | $15.64 | $24.12 | $21.47 | $18.33 | $16.23 | $14.55 | $12.45 | $10.95 | $7.37 | $6.10 | $5.78 | |
| EPS (Diluted) | $13.23 | $15.51 | $23.86 | $21.18 | $18.08 | $16.03 | $14.33 | $12.19 | $10.72 | $7.25 | $6.01 | $5.70 | |
| Shares (Basic) | 908,000,000 | 921,000,000 | 928,000,000 | 937,000,000 | 943,000,000 | 949,000,000 | 951,000,000 | 963,000,000 | 964,000,000 | 952,000,000 | 953,000,000 | 972,000,000 | |
| Shares (Diluted) | 911,000,000 | 929,000,000 | 938,000,000 | 950,000,000 | 956,000,000 | 961,000,000 | 966,000,000 | 983,000,000 | 985,000,000 | 968,000,000 | 967,000,000 | 986,000,000 | |
| EBITDA | $18.96B | $32.29B | $32.36B | $28.43B | $23.97B | $22.41B | $19.68B | $17.34B | $15.21B | $12.93B | $11.02B | $10.27B |
Bilanço 26
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $24.36B | $25.31B | $25.43B | $23.36B | $21.38B | $16.92B | $10.98B | $10.87B | $11.98B | $10.43B | $10.92B | $7.50B | |
| Short-term Investments | $3.76B | $3.80B | $4.20B | $4.55B | $2.53B | $2.86B | $3.26B | $3.46B | $3.51B | $2.85B | $1.99B | $1.74B | |
| Receivables | $23.02B | $22.36B | $21.28B | $17.68B | $14.22B | $12.87B | $11.82B | $11.39B | $9.57B | $8.15B | $6.52B | $4.25B | |
| Inventory | $3.30B | $3.80B | $2.80B | $3.50B | $2.90B | · | · | · | · | · | · | · | |
| Prepaid Expense | $9.75B | $8.21B | $6.08B | $6.62B | $5.32B | $4.46B | $3.85B | $3.09B | $2.66B | $1.85B | $2.41B | $1.05B | |
| Current Assets | $90.58B | $85.78B | $78.44B | $69.07B | $61.76B | $53.72B | $42.63B | $38.69B | $37.08B | $33.88B | $31.64B | $23.56B | |
| PP&E (Net) | $10.76B | $10.55B | $11.45B | $10.13B | $8.97B | $8.63B | $8.70B | $8.46B | $7.01B | $5.90B | $4.86B | $4.42B | |
| Accum. Depreciation | $7.55B | $6.97B | $7.04B | $6.93B | $5.99B | $5.23B | $5.00B | $4.14B | $3.69B | $3.75B | $3.17B | $2.95B | |
| Goodwill | $110.50B | $106.73B | $103.73B | $93.35B | $75.80B | $71.34B | $65.66B | $58.91B | $54.56B | $47.58B | $44.45B | $32.94B | |
| Intangibles | $20.47B | $23.27B | $15.19B | $14.40B | $10.04B | $10.86B | $10.35B | $9.32B | $8.49B | $8.54B | $8.39B | $3.67B | |
| Other Non-current Assets | $23.01B | $19.59B | $17.30B | $15.03B | $12.53B | $11.51B | $9.33B | $4.33B | $3.58B | $3.04B | $3.12B | $2.97B | |
| Total Assets | $309.58B | $298.28B | $273.72B | $245.71B | $212.21B | $197.29B | $173.89B | $152.22B | $139.06B | $122.81B | $111.25B | $86.30B | |
| Accounts Payable | $38.03B | $34.34B | $31.96B | $27.71B | $24.64B | $22.50B | $19.00B | $16.70B | $15.18B | $13.36B | $11.99B | $9.25B | |
| Current Liabilities | $114.90B | $103.77B | $99.05B | $89.24B | $78.29B | $72.42B | $61.78B | $53.21B | $50.46B | $49.25B | $42.90B | $30.62B | |
| Deferred Tax | $2.42B | $3.62B | $3.02B | $2.77B | $3.27B | $3.37B | $2.99B | $2.47B | $2.18B | $2.76B | $3.59B | $2.06B | |
| Other Non-current Liabilities | $18.25B | $15.94B | $14.46B | $12.84B | $11.79B | $12.31B | $10.14B | $5.73B | $5.56B | $4.83B | $1.48B | $1.36B | |
| Total Liabilities | $207.88B | $195.69B | $174.80B | $159.36B | $135.73B | $126.75B | $111.73B | $95.99B | $87.04B | $82.62B | $75.79B | $52.54B | |
| Long-term Debt | · | · | · | · | $46.00B | $43.47B | $40.68B | $36.55B | $31.69B | $32.97B | $31.96B | $17.41B | |
| Total Debt | $72.32B | $72.36B | $58.26B | $54.51B | $46.00B | $43.47B | $40.68B | $36.55B | $31.69B | $32.97B | $32.09B | $17.41B | |
| Common Stock | $9M | $9M | $9M | $9M | $10M | $10M | $9M | $10M | $10M | $10M | $10M | $10M | |
| Paid-in Capital | $559M | $0 | $0 | · | $0 | $0 | $7M | $0 | $1.70B | $0 | $29M | $0 | |
| Retained Earnings | $95.60B | $96.04B | $95.77B | $86.16B | $77.13B | $69.30B | $61.18B | $55.85B | $48.73B | $40.95B | $37.12B | $33.84B | |
| AOCI | $-2.06B | $-3.39B | $-7.03B | $-8.39B | $-5.38B | $-3.81B | $-3.58B | $-4.16B | $-2.67B | $-2.68B | $-3.33B | $-1.39B | |
| Stockholders' Equity | $100.09B | $98.27B | $94.42B | $81.45B | $75.05B | $68.33B | $60.44B | $54.32B | $49.83B | $38.18B | $33.73B | $32.45B | |
| Liabilities + Equity | $309.58B | $298.28B | $273.72B | $245.71B | $212.21B | $197.29B | $173.89B | $152.22B | $139.06B | $122.81B | $111.25B | $86.38B | |
| Shares Outstanding | 906,000,000 | 915,000,000 | 924,000,000 | 934,000,000 | 941,000,000 | 946,000,000 | 948,000,000 | 960,000,000 | 969,000,000 | 952,000,000 | 953,000,000 | 954,000,000 |
Nakit Akışı 18
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $4.36B | $4.10B | $3.97B | $3.40B | $3.10B | $2.89B | $2.72B | $2.43B | $2.25B | $2.06B | $1.69B | $1.48B | |
| Stock-based Comp | $971M | $1.02B | $1.06B | $925M | $800M | $679M | $697M | $638M | $597M | $485M | $406M | $364M | |
| Deferred Tax | $-1.75B | $-296M | $-245M | $-673M | $130M | $-8M | $230M | $42M | $-965M | $81M | $-73M | $-117M | |
| Amort. of Intangibles | $1.70B | $1.70B | $1.60B | $1.30B | $1.20B | $1.10B | $1.00B | $898M | $896M | $882M | $650M | $524M | |
| Operating Cash Flow | $19.70B | $24.20B | $29.07B | $26.21B | $22.34B | $22.17B | $18.46B | $15.71B | $13.60B | $9.79B | $9.74B | $8.05B | |
| CapEx | $3.62B | $3.50B | $3.39B | $2.80B | $2.45B | $2.05B | $2.07B | $2.06B | $2.02B | $1.71B | $1.56B | $1.52B | |
| Investing Cash Flow | $-8.69B | $-20.53B | $-15.57B | $-28.48B | $-10.37B | $-12.53B | $-12.70B | $-12.38B | $-8.60B | $-9.36B | $-18.39B | $-2.53B | |
| Debt Issued | $2.97B | $17.81B | $6.39B | $14.82B | $6.93B | $4.86B | $5.44B | $6.93B | $5.29B | $3.97B | $11.98B | $2.00B | |
| Net Debt Issued | $-81M | $14.81B | $4.27B | $11.80B | $3.78B | $1.71B | $3.69B | $4.33B | $893M | $1.37B | $10.94B | $1.19B | |
| Stock Issued | $827M | $1.85B | $1.35B | $1.25B | $1.35B | $1.44B | $1.04B | $838M | $688M | $429M | $402M | $462M | |
| Stock Repurchased | $5.54B | $9.00B | $8.00B | $7.00B | $5.00B | $4.25B | $5.50B | $4.50B | $1.50B | $1.28B | $1.20B | $4.01B | |
| Net Stock Activity | $-4.72B | $-7.15B | $-6.65B | $-5.75B | $-3.65B | $-2.81B | $-4.46B | $-3.66B | $-812M | $-851M | $-798M | $-3.55B | |
| Dividends Paid | $7.92B | $7.53B | $6.76B | $5.99B | $5.28B | $4.58B | $3.93B | $3.32B | $2.77B | $2.26B | $1.79B | $1.36B | |
| Financing Cash Flow | $-11.64B | $-3.51B | $-11.53B | $4.23B | $-7.46B | $-3.59B | $-5.62B | $-4.37B | $-3.44B | $-1.01B | $12.24B | $-5.29B | |
| Net Change in Cash | $-947M | $-115M | $2.06B | $1.99B | $4.45B | $5.94B | $119M | $-1.11B | $1.55B | $-493M | $3.43B | $219M | |
| Taxes Paid | $3.71B | $4.62B | $6.08B | $5.22B | $3.97B | $4.93B | $3.54B | $3.26B | $4.00B | $4.73B | $4.40B | $4.02B | |
| Free Cash Flow | $16.07B | $20.70B | $25.68B | $23.40B | $19.89B | $20.12B | $16.39B | $13.65B | $11.57B | $8.09B | $8.18B | $6.53B | |
| Levered FCF | $12.59B | $17.74B | $23.10B | $21.76B | $18.57B | $18.86B | $15.04B | $12.56B | $10.66B | $7.45B | $7.73B | $6.17B |
Kârlılık 7
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 4.2% | 8.1% | 8.7% | 8.8% | 8.3% | 8.7% | 8.1% | 7.7% | 7.6% | 7.0% | 7.0% | 7.9% | |
| Net Margin | 2.7% | 3.6% | 6.0% | 6.2% | 6.0% | 6.0% | 5.7% | 5.3% | 5.2% | 3.8% | 3.7% | 4.3% | |
| Pretax Margin | 3.3% | 5.0% | 7.8% | 8.1% | 7.8% | 8.1% | 7.4% | 7.0% | 7.0% | 6.4% | 6.5% | 7.4% | |
| EBITDA Margin | 4.2% | 8.1% | 8.7% | 8.8% | 8.3% | 8.7% | 8.1% | 7.7% | 7.6% | 7.0% | 7.0% | 7.9% | |
| ROA | 4.0% | 4.8% | 8.6% | 8.8% | 8.4% | 8.3% | 8.5% | 8.2% | 8.1% | 6.0% | 5.9% | 6.7% | |
| ROE | 12.0% | 14.5% | 24.3% | 25.2% | 23.3% | 22.6% | 23.4% | 22.4% | 21.7% | 18.5% | 17.4% | 17.3% | |
| ROIC | 9.6% | 14.4% | 16.9% | 16.4% | 15.7% | 15.2% | 15.4% | 14.8% | 14.4% | 10.8% | 9.6% | 12.0% |
Likidite ve Solventlik 5
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.8 | 0.8 | 0.8 | 0.8 | 0.8 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 0.8 | |
| Quick Ratio | 0.4 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.4 | 0.5 | 0.5 | 0.4 | 0.5 | 0.4 | |
| Debt / Equity | 0.7 | 0.7 | 0.6 | 0.7 | 0.6 | 0.6 | 0.7 | 0.7 | 0.6 | 0.9 | 1.0 | 0.5 | |
| LT Debt / Equity | 0.7 | 0.7 | 0.6 | 0.7 | 0.6 | 0.6 | 0.6 | 0.6 | 0.6 | 0.7 | 0.8 | 0.5 | |
| Interest Coverage | 4.7 | 8.3 | 10.0 | 13.6 | 14.4 | 13.5 | 11.6 | 12.4 | 12.8 | 12.1 | 14.0 | 16.6 |
Verimlilik 3
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 1.5 | 1.3 | 1.4 | 1.4 | 1.4 | 1.4 | 1.5 | 1.6 | 1.5 | 1.6 | 1.6 | 1.6 | |
| Inventory Turnover | 14.3 | 14.1 | 12.3 | 10.5 | · | · | · | · | · | · | · | · | |
| Receivables Turnover | 19.7 | 18.3 | 19.1 | 20.3 | 21.2 | 20.8 | 20.9 | 21.6 | 22.7 | 25.2 | 29.2 | 35.7 |
Büyüme Oranları 10
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 11.8% | 7.7% | 14.6% | 12.7% | 11.8% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 11.3% | 11.7% | 13.1% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 11.7% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | -14.7% | -35.0% | 12.7% | 17.2% | 12.8% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | -14.5% | -5.0% | 14.2% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | -3.8% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | -16.3% | -35.6% | 11.2% | 16.4% | 12.2% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | -15.7% | -5.9% | 13.3% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | -4.8% | · | · | · | · | · | · | · | · | · | · | · | |
| Dividend CAGR 5Y | 11.6% | · | · | · | · | · | · | · | · | · | · | · |
Değerleme (TTM) 16
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $447.57B | $400.28B | $371.62B | $324.16B | $287.60B | $257.14B | $242.16B | $226.25B | $201.16B | $184.84B | $157.11B | $130.47B | |
| Net Income TTM | $12.06B | $14.40B | $22.38B | $20.12B | $17.29B | $15.40B | $13.84B | $11.99B | $10.56B | $7.02B | $5.81B | $5.62B | |
| Market Cap | $299.08B | $462.86B | $486.46B | $495.19B | $472.51B | $331.74B | $278.69B | $239.16B | $213.63B | $152.36B | $112.11B | $96.44B | |
| Enterprise Value | $343.28B | $506.11B | $515.09B | $521.79B | $494.61B | $355.43B | $305.13B | $261.39B | $229.83B | $172.05B | $131.29B | $104.61B | |
| P/E | 25.0 | 32.6 | 22.1 | 25.0 | 27.8 | 21.9 | 20.5 | 20.4 | 20.6 | 22.1 | 19.6 | 17.7 | |
| P/S | 0.7 | 1.2 | 1.3 | 1.5 | 1.6 | 1.3 | 1.2 | 1.1 | 1.1 | 0.8 | 0.7 | 0.7 | |
| P/B | 3.0 | 4.7 | 5.2 | 6.1 | 6.3 | 4.9 | 4.6 | 4.4 | 4.3 | 4.0 | 3.3 | 3.0 | |
| P / Cash Flow | 15.2 | 19.1 | 16.7 | 18.9 | 21.1 | 15.0 | 15.1 | 15.2 | 15.7 | 15.6 | 11.5 | 12.0 | |
| P / FCF | 18.6 | 22.4 | 18.9 | 21.2 | 23.8 | 16.5 | 17.0 | 17.5 | 18.5 | 18.8 | 13.7 | 14.8 | |
| EV / EBITDA | 18.1 | 15.7 | 15.9 | 18.4 | 20.6 | 15.9 | 15.5 | 15.1 | 15.1 | 13.3 | 11.9 | 10.2 | |
| EV / FCF | 21.4 | 24.4 | 20.1 | 22.3 | 24.9 | 17.7 | 18.6 | 19.1 | 19.9 | 21.3 | 16.0 | 16.0 | |
| EV / Revenue | 0.8 | 1.3 | 1.4 | 1.6 | 1.7 | 1.4 | 1.3 | 1.2 | 1.1 | 0.9 | 0.8 | 0.8 | |
| Dividend Yield | 2.6% | 1.6% | 1.4% | 1.2% | 1.1% | 1.4% | 1.4% | 1.4% | 1.3% | 1.5% | 1.6% | 1.4% | |
| Earnings Yield | 4.0% | 3.1% | 4.5% | 4.0% | 3.6% | 4.6% | 4.9% | 4.9% | 4.9% | 4.5% | 5.1% | 5.6% | |
| Payout Ratio | 65.7% | 52.3% | 30.2% | 29.8% | 30.6% | 29.8% | 28.4% | 27.7% | 26.3% | 32.2% | 30.7% | 24.2% | |
| Annual Payout | $7.92B | $7.53B | $6.76B | $5.99B | $5.28B | $4.58B | $3.93B | $3.32B | $2.77B | $2.26B | $1.79B | $1.36B |
Gelir Tablosu 14
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $111.72B | $113.22B | $113.16B | $111.62B | $109.58B | $100.81B | $100.82B | $98.86B | $99.80B | $94.43B | $92.36B | $92.90B | $91.93B | $82.79B | $80.89B | $80.33B | |
| Cost of Revenue | $12.82B | $12.68B | $12.57B | $13.02B | $12.39B | $12.46B | $11.83B | $11.34B | $11.06B | $10.19B | $9.42B | $9.75B | $9.40B | $8.31B | $8.31B | $8.60B | |
| SG&A Expense | $15.39B | $17.00B | $15.22B | $13.78B | $13.59B | $12.49B | $13.28B | $13.16B | $14.08B | $13.34B | $13.86B | $13.81B | $13.62B | $13.01B | $11.66B | $11.71B | |
| Operating Expenses | $102.73B | $112.83B | $108.85B | $106.47B | $100.46B | $93.03B | $92.11B | $90.98B | $91.86B | $86.74B | $83.83B | $84.85B | $83.84B | $75.90B | $73.43B | $73.20B | |
| Operating Income | $8.99B | $380M | $4.32B | $5.15B | $9.12B | $7.77B | $8.71B | $7.88B | $7.93B | $7.69B | $8.53B | $8.06B | $8.09B | $6.89B | $7.46B | $7.13B | |
| Interest Expense | $955M | $974M | $1.00B | $1.03B | $998M | $1.00B | $1.07B | $985M | $844M | $830M | $834M | $828M | $754M | $676M | $516M | $467M | |
| Pretax Income | $7.96B | $-720M | $3.23B | $4.08B | $8.11B | $6.79B | $7.61B | $5.67B | $1M | $6.86B | $7.69B | $7.23B | $7.33B | $6.21B | $6.95B | $6.67B | |
| Income Tax | $1.48B | $-938M | $686M | $510M | $1.63B | $1.01B | $1.36B | $1.24B | $1.22B | $1.18B | $1.65B | $1.57B | $1.56B | $1.31B | $1.56B | $1.47B | |
| Net Income | $6.28B | $10M | $2.35B | $3.41B | $6.29B | $5.54B | $6.05B | $4.22B | $-1.41B | $5.46B | $5.84B | $5.47B | $5.61B | $4.76B | $5.26B | $5.07B | |
| EPS (Basic) | $6.92 | $0.03 | $2.59 | $3.76 | $6.90 | $6.03 | $6.56 | $4.58 | $-1.53 | $5.91 | $6.31 | $5.89 | $6.01 | $5.09 | $5.63 | $5.41 | |
| EPS (Diluted) | $6.90 | $0.05 | $2.59 | $3.74 | $6.85 | $5.99 | $6.51 | $4.54 | $-1.53 | $5.85 | $6.24 | $5.82 | $5.95 | $5.02 | $5.55 | $5.34 | |
| Shares (Basic) | 908,000,000 | -1,817,000,000 | 906,000,000 | 907,000,000 | 912,000,000 | -1,845,000,000 | 923,000,000 | 921,000,000 | 922,000,000 | -1,861,000,000 | 926,000,000 | 930,000,000 | 933,000,000 | -1,876,000,000 | 935,000,000 | 937,000,000 | |
| Shares (Diluted) | 910,000,000 | -1,825,000,000 | 908,000,000 | 910,000,000 | 918,000,000 | -1,851,000,000 | 930,000,000 | 928,000,000 | 922,000,000 | -1,881,000,000 | 936,000,000 | 940,000,000 | 943,000,000 | -1,902,000,000 | 948,000,000 | 950,000,000 | |
| EBITDA | $8.99B | · | $4.32B | $5.15B | $9.12B | · | $8.71B | $7.88B | $7.93B | · | $8.53B | $8.06B | $8.09B | · | $7.46B | $7.13B |
Bilanço 26
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $28.00B | $24.36B | $27.21B | $28.60B | $30.72B | $25.31B | $32.40B | $26.29B | $28.41B | · | $38.91B | $41.81B | $41.91B | · | $38.84B | $24.61B | |
| Short-term Investments | $3.23B | $3.76B | $3.40B | $3.42B | $3.57B | $3.80B | $4.73B | $5.04B | $4.30B | · | $5.18B | $4.47B | $4.58B | · | $3.68B | $3.35B | |
| Receivables | $26.59B | $23.02B | $22.67B | $24.14B | $26.94B | $22.36B | $20.02B | $23.11B | $27.20B | · | $20.67B | $17.95B | $22.41B | · | $17.05B | $18.72B | |
| Inventory | · | $3.30B | · | · | · | $3.80B | · | · | · | · | · | · | · | · | · | · | |
| Prepaid Expense | $8.72B | $9.75B | $9.02B | $8.96B | $9.04B | $8.21B | $7.64B | $7.42B | $6.13B | · | $5.77B | $5.88B | $6.45B | · | $5.66B | $5.22B | |
| Current Assets | $91.13B | $90.58B | $95.07B | $93.70B | $96.28B | $85.78B | $92.26B | $92.04B | $88.94B | · | $91.91B | $89.87B | $93.89B | · | $82.94B | $68.36B | |
| PP&E (Net) | $10.67B | $10.76B | $11.10B | $10.92B | $10.73B | $10.55B | $10.14B | $9.80B | $10.43B | · | $11.07B | $10.93B | $10.64B | · | $9.47B | $9.42B | |
| Accum. Depreciation | · | $7.55B | · | · | · | $6.97B | · | · | · | · | · | · | · | · | · | · | |
| Goodwill | $110.51B | $110.50B | $110.34B | $107.68B | $107.57B | $106.73B | $105.98B | $105.44B | $105.66B | $103.73B | $101.70B | $101.67B | $100.41B | $93.35B | $83.90B | $84.16B | |
| Intangibles | $20.09B | $20.47B | $22.79B | $22.51B | $22.95B | $23.27B | $23.59B | $14.73B | $15.54B | · | $15.20B | $15.64B | $16.16B | · | $10.79B | $11.29B | |
| Other Non-current Assets | $23.46B | $23.01B | $22.98B | $21.30B | $20.39B | $19.59B | $18.65B | $17.94B | $17.70B | · | $16.71B | $16.07B | $15.69B | · | $14.41B | $14.52B | |
| Total Assets | $312.64B | $309.58B | $315.27B | $308.57B | $309.79B | $298.28B | $299.31B | $286.06B | $284.21B | $273.72B | $282.06B | $280.16B | $283.68B | $245.71B | $243.06B | $230.17B | |
| Accounts Payable | $38.63B | $38.03B | $36.03B | $34.33B | $33.57B | $34.34B | $33.08B | $30.89B | $30.74B | · | $31.16B | $29.52B | $29.86B | · | $27.23B | $25.14B | |
| Short-term Debt | · | · | · | · | · | · | · | · | $7.30B | · | $2.60B | $4.40B | $8.20B | · | · | · | |
| Current Liabilities | $114.12B | $114.90B | $115.53B | $110.78B | $113.47B | $103.77B | $101.56B | $104.67B | $104.43B | · | $114.18B | $112.98B | $116.48B | · | $100.94B | $88.70B | |
| Deferred Tax | $2.86B | $2.42B | $3.16B | $3.80B | $3.90B | $3.62B | $4.01B | $3.63B | $4.17B | · | $2.21B | $2.50B | $2.83B | · | $1.66B | $2.58B | |
| Other Non-current Liabilities | $18.90B | $18.25B | $18.37B | $15.71B | $15.96B | $15.94B | $15.17B | $14.79B | $14.84B | · | $13.62B | $13.26B | $13.08B | · | $12.11B | $11.97B | |
| Total Liabilities | $207.32B | $207.88B | $209.46B | $203.79B | $204.62B | $195.69B | $194.85B | $186.82B | $187.29B | · | $188.08B | $188.01B | $193.06B | · | $160.14B | $149.04B | |
| Total Debt | $71.44B | · | $72.40B | $73.50B | $71.28B | · | $74.10B | $63.73B | $71.15B | · | $60.68B | $63.67B | $68.86B | · | $45.44B | $45.80B | |
| Common Stock | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | · | $9M | $9M | $9M | · | $10M | $10M | |
| Paid-in Capital | $556M | $559M | $394M | · | · | $0 | $461M | $373M | · | · | · | · | · | · | · | · | |
| Retained Earnings | $99.88B | $95.60B | $97.59B | $97.25B | $97.93B | $96.04B | $96.52B | $92.40B | $90.12B | · | $93.17B | $89.99B | $88.85B | · | $83.72B | $80.54B | |
| AOCI | $-2.56B | $-2.06B | $-2.21B | $-2.54B | $-2.90B | $-3.39B | $-2.45B | $-3.42B | $-3.44B | · | $-8.69B | $-7.65B | $-7.55B | · | $-9.09B | $-7.73B | |
| Stockholders' Equity | $103.89B | $100.09B | $101.57B | $100.47B | $100.81B | $98.27B | $99.88B | $94.68B | $92.37B | $94.42B | $89.56B | $87.37B | $85.82B | $81.45B | $78.06B | $76.20B | |
| Liabilities + Equity | $312.64B | $309.58B | $315.27B | $308.57B | $309.79B | $298.28B | $299.31B | $286.06B | $284.21B | · | $282.06B | $280.16B | $283.68B | · | $243.06B | $230.17B | |
| Shares Outstanding | 908,000,000 | 906,000,000 | 906,000,000 | 905,000,000 | 910,000,000 | 915,000,000 | 923,000,000 | 921,000,000 | 920,000,000 | 924,000,000 | 925,000,000 | 927,000,000 | 932,000,000 | 934,000,000 | 935,000,000 | 935,000,000 |
Nakit Akışı 16
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $1.03B | $1.12B | $1.10B | $1.08B | $1.06B | $1.04B | $1.04B | $1.02B | $997M | $974M | $1.01B | $1.02B | $970M | $982M | $828M | $802M | |
| Stock-based Comp | $348M | $176M | $223M | $197M | $375M | $187M | $237M | $222M | $372M | $208M | $247M | $242M | $362M | $250M | $171M | $205M | |
| Deferred Tax | $540M | $-733M | $-932M | $-151M | $64M | $-62M | $124M | $-331M | $-27M | $249M | $-12M | $-150M | $-332M | $-83M | $-575M | $-176M | |
| Operating Cash Flow | $8.91B | $1.11B | $5.95B | $7.19B | $5.46B | $2.37B | $13.95B | $6.75B | $1.14B | $-5.19B | $6.90B | $11.03B | $16.33B | $-4.53B | $18.55B | $6.87B | |
| CapEx | $763M | $948M | $890M | $886M | $898M | $912M | $991M | $853M | $743M | $959M | $838M | $829M | $760M | $866M | $724M | $657M | |
| Investing Cash Flow | $-2.45B | $-2.61B | $-4.56B | $-1.44B | $-74M | $-1.12B | $-5.65B | $-7.42B | $-6.34B | $-1.19B | $-2.64B | $-728M | $-11.02B | $-15.37B | $-847M | $-8.59B | |
| Debt Issued | · | $0 | $0 | $2.97B | $0 | $0 | $11.89B | $0 | $5.92B | $0 | $0 | $-7M | $6.40B | $8.90B | $0 | $5.92B | |
| Net Debt Issued | $-1.50B | · | · | · | $0 | · | · | · | $5.17B | · | · | · | $5.03B | · | · | · | |
| Stock Issued | $231M | $24M | $222M | $221M | $360M | $235M | $867M | $258M | $486M | $314M | $411M | $284M | $344M | $169M | $328M | $205M | |
| Stock Repurchased | $0 | $0 | $0 | $2.54B | $3.00B | $4.97B | $956M | $0 | $3.07B | $1.50B | $1.50B | $3.00B | $2.00B | $1.00B | $1.00B | $2.50B | |
| Net Stock Activity | $231M | · | · | · | $-2.64B | · | · | · | $-2.59B | · | · | · | $-1.66B | · | · | · | |
| Dividends Paid | $2.00B | $2.00B | $2.00B | $2.00B | $1.91B | $1.93B | $1.94B | $1.94B | $1.73B | $1.74B | $1.74B | $1.75B | $1.54B | $1.54B | $1.54B | $1.54B | |
| Financing Cash Flow | $-2.99B | $-1.03B | $-2.77B | $-7.95B | $99M | $-8.34B | $-2.21B | $-1.20B | $8.23B | $-7.16B | $-7.10B | $-10.46B | $13.19B | $4.39B | $-3.42B | $946M | |
| Net Change in Cash | $3.64B | $-2.85B | $-1.39B | $-2.12B | $5.41B | $-7.09B | $6.11B | $-2.13B | $2.99B | $-13.49B | $-2.90B | $-100M | $18.55B | $-15.48B | $14.23B | $-870M | |
| Free Cash Flow | $8.15B | · | · | · | $4.56B | · | · | · | $401M | · | · | · | $15.57B | · | · | · | |
| Levered FCF | $7.37B | · | · | · | $3.76B | · | · | · | $1.03T | · | · | · | $14.97B | · | · | · |
Kârlılık 7
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 8.1% | · | 3.8% | 4.6% | 8.3% | · | 8.6% | 8.0% | 8.0% | · | 9.2% | 8.7% | 8.8% | · | 9.2% | 8.9% | |
| Net Margin | 5.6% | · | 2.1% | 3.0% | 5.7% | · | 6.0% | 4.3% | -1.4% | · | 6.3% | 5.9% | 6.1% | · | 6.5% | 6.3% | |
| Pretax Margin | 7.1% | · | 2.9% | 3.7% | 7.4% | · | 7.5% | 5.7% | 0.00% | · | 8.3% | 7.8% | 8.0% | · | 8.6% | 8.3% | |
| EBITDA Margin | 8.1% | · | 3.8% | 4.6% | 8.3% | · | 8.6% | 8.0% | 8.0% | · | 9.2% | 8.7% | 8.8% | · | 9.2% | 8.9% | |
| ROA | 2.0% | · | 0.76% | 1.1% | 2.1% | · | 2.1% | 1.5% | -0.50% | · | 2.2% | 2.1% | 2.2% | · | 2.3% | 2.3% | |
| ROE | 6.1% | · | 2.3% | 3.5% | 6.5% | · | 6.4% | 4.6% | -1.6% | · | 7.0% | 6.7% | 6.9% | · | 7.0% | 6.8% | |
| ROIC | 4.2% | · | 1.9% | 2.6% | 4.2% | · | 4.1% | 3.9% | -5922.1% | · | 4.5% | 4.2% | 4.1% | · | 4.7% | 4.6% |
Likidite ve Solventlik 5
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.8 | · | 0.8 | 0.8 | 0.8 | · | 0.9 | 0.9 | 0.9 | · | 0.8 | 0.8 | 0.8 | · | 0.8 | 0.8 | |
| Quick Ratio | 0.5 | · | 0.5 | 0.5 | 0.5 | · | 0.6 | 0.5 | 0.6 | · | 0.6 | 0.6 | 0.6 | · | 0.6 | 0.5 | |
| Debt / Equity | 0.7 | · | 0.7 | 0.7 | 0.7 | · | 0.7 | 0.7 | 0.8 | · | 0.7 | 0.7 | 0.8 | · | 0.6 | 0.6 | |
| LT Debt / Equity | 0.7 | · | 0.7 | 0.7 | 0.7 | · | 0.7 | 0.7 | 0.7 | · | 0.6 | 0.7 | 0.7 | · | 0.6 | 0.6 | |
| Interest Coverage | 9.4 | · | 4.3 | 5.0 | 9.1 | · | 8.1 | 8.0 | 9.4 | · | 10.2 | 9.7 | 10.7 | · | 14.5 | 15.3 |
Verimlilik 2
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.4 | · | 0.4 | 0.4 | 0.4 | · | 0.3 | 0.3 | 0.4 | · | 0.4 | 0.4 | 0.4 | · | 0.4 | 0.4 | |
| Receivables Turnover | 4.2 | · | 5.3 | 4.7 | 4.0 | · | 5.0 | 4.8 | 4.0 | · | 4.9 | 5.1 | 4.5 | · | 5.2 | 4.8 |
Değerleme (TTM) 14
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $446.07B | · | $435.17B | $420.87B | $409.05B | · | $391.83B | $383.92B | $376.99B | · | $358.09B | $346.06B | $333.31B | · | $313.71B | $304.14B | |
| Net Income TTM | $18.33B | · | $18.10B | $19.97B | $15.15B | · | $14.70B | $14.12B | $15.52B | · | $22.19B | $21.42B | $20.97B | · | $19.45B | $18.45B | |
| Market Cap | $245.70B | · | $312.84B | $282.33B | $476.61B | · | $539.66B | $469.03B | $455.12B | · | $466.38B | $445.55B | $440.45B | · | $472.21B | $480.24B | |
| Enterprise Value | $285.91B | · | $354.63B | $323.81B | $513.61B | · | $576.63B | $501.43B | $493.56B | · | $482.96B | $462.94B | $462.81B | · | $475.12B | $498.08B | |
| P/E | 13.5 | · | 17.5 | 14.4 | 32.0 | · | 37.1 | 33.8 | 30.0 | · | 21.4 | 21.2 | 21.4 | · | 24.7 | 26.5 | |
| P/S | 0.6 | · | 0.7 | 0.7 | 1.2 | · | 1.4 | 1.2 | 1.2 | · | 1.3 | 1.3 | 1.3 | · | 1.5 | 1.6 | |
| P/B | 2.4 | · | 3.1 | 2.8 | 4.7 | · | 5.4 | 5.0 | 4.9 | · | 5.2 | 5.1 | 5.1 | · | 6.0 | 6.3 | |
| P / Cash Flow | 27.6 | · | · | · | 87.4 | · | · | · | 397.8 | · | · | · | 27.0 | · | · | · | |
| P / FCF | 30.2 | · | · | · | 104.6 | · | · | · | 1135.0 | · | · | · | 28.3 | · | · | · | |
| EV / EBITDA | 31.8 | · | 82.2 | 62.9 | 56.3 | · | 66.2 | 63.7 | 62.2 | · | 56.6 | 57.5 | 57.2 | · | 63.7 | 69.8 | |
| EV / FCF | 35.1 | · | · | · | 112.7 | · | · | · | 1230.8 | · | · | · | 29.7 | · | · | · | |
| EV / Revenue | 0.6 | · | 0.8 | 0.8 | 1.3 | · | 1.5 | 1.3 | 1.3 | · | 1.3 | 1.3 | 1.4 | · | 1.5 | 1.6 | |
| Earnings Yield | 7.4% | · | 5.7% | 6.9% | 3.1% | · | 2.7% | 3.0% | 3.3% | · | 4.7% | 4.7% | 4.7% | · | 4.0% | 3.8% | |
| Payout Ratio | 31.9% | · | · | · | 30.4% | · | · | · | -122.7% | · | · | · | 27.4% | · | · | · |
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
Gelir Tablosu
| 2025-12-31 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| Gelir | $447.57B | — | $400.28B | — | — |
| Faaliyet Kâr Marjı % | 4.2% | — | 8.1% | — | — |
| Net Gelir | $12.06B | — | $14.40B | — | — |
| Seyreltilmiş Hisse Başı Kâr | $13.23 | — | $15.51 | — | — |
Bilanço
| 2025-12-31 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| Borç / Öz Sermaye | 0.7 | — | 0.7 | — | — |
| Cari Oran | 0.8 | — | 0.8 | — | — |
| Cari Oran | 0.4 | — | 0.5 | — | — |
Nakit Akışı
| 2025-12-31 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| Serbest Nakit Akışı | $16.07B | — | $20.70B | — | — |
Son Haberler Bu şirketten bahseden son manşetler
- UnitedHealth (UNH) Hisseleri Berkshire Hathaway Çıkışının Ardından Düşüşte, Reuters Bildiriyor
- Berkshire Hathaway Birleşik Sağlık payını 2026'nın 1. çeyreğinde terk etti
- UnitedHealth Group hissesi, Berkshire Hathaway'in sağlık sigortacısındaki pozisyonundan çıkmasının ardından düştü
- UnitedHealth Group (UNH) Düşüşü %33 Oldu: Artan Tıbbi Maliyetler ve Üye Karışımı, Kazançları Baskıladı
- UnitedHealth Hissesiyle Neler Oluyor?
- UnitedHealth Hissesi Tekrar Almak Güvenli mi?
- UnitedHealth Warren Buffett'ı Haklı Çıkardı -- Yine
- UnitedHealth Group Incorporated Q1 2026 Karar Bildirimi Özeti
- Nisan 20-24 Opsiyon Volatilitesi ve Kazanç Raporu
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
📊
Sizin için önemli olan metrikleri seçin — yukarıdaki Tam Temeller'deki herhangi bir satırın yanındaki ➕ düğmesine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.